Company news
Quest Diagnostics Incorporated (NYSE:DGX) news
Quest Diagnostics Incorporated news releases on 6ix. Latest, Sep 24, 2025: Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden…
Press releases — page 2
Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States
September 24, 2025
Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration
September 23, 2025
Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer
September 22, 2025
WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP App
September 18, 2025
Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference
September 15, 2025
Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering
September 4, 2025
Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index
September 2, 2025
Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan
August 26, 2025
FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics
August 25, 2025
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
August 15, 2025
Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types
August 7, 2025
Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care
August 5, 2025
Exposure to PFAS in drinking water linked to higher blood levels of these "forever" chemicals
July 30, 2025
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing
July 29, 2025
Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
July 22, 2025
Quest Diagnostics Introduces Testing for Oropouche Virus
July 15, 2025
Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease
July 9, 2025
Quest Diagnostics Releases 2024 Corporate Responsibility Report
June 25, 2025
Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025
June 23, 2025
PreciseDx Continues Path to Commercial Launch: Secures Additional Funding and Announces New Leadership
June 18, 2025
Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
June 10, 2025
More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals
May 20, 2025
Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference
May 16, 2025
Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds
May 13, 2025
Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025
April 22, 2025